SEC Form 4 · accession 0000899243-18-029964
MELINTA THERAPEUTICS, INC. /NEW/ · MLNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bruce Downey
Director
Period of report
Nov 30, 2018
Accepted (ET)
Dec 3, 2018 · 5:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001461993
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.12 | Nov 30, 2018 | A | 25,000 | A | — | Oct 31, 2028 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1One-third of the shares underlying the stock option will vest and become exercisable on October 31, 2019. The remainder will vest and become exercisable in substantially equal monthly installments during the two year period commencing on October 31, 2019.